October 9, 2017
October 9, 2017 —
An international team of researchers at University of California San Diego School of Medicine and Moores Cancer Center, with colleagues at Sun Yet-sun University Cancer Center and other collaborating institutions, have developed a new diagnostic and prognosis method for early detection of hepatocellular carcinoma (HCC), based on a simple blood…
October 12, 2018
October 12, 2018 —
…pancreatic neuroendocrine cancer for more than three years. Current treatments, although effective for her, are highly toxic. Tamara enrolled in a first-of-its-kind, pilot study at Moores Cancer Center at UC San Diego Health to test a personalized vaccine using her unique cancer mutations to boost an anti-tumor immune response.
January 17, 2017
January 17, 2017 —
Researchers at University of California San Diego School of Medicine, with colleagues at the National Institute of Diabetes and Digestive and Kidney Diseases, the University of Manitoba and St. Boniface Hospital Albrechtsen Research Centre in Canada, have identified a molecular signaling pathway that, when blocked, promotes sensory neuron growth and…
October 11, 2016
October 11, 2016 —
Combining multiple non-invasive measures, researchers at University of California San Diego School of Medicine describe a novel method to quantify the progression of nonalcoholic fatty liver disease (NAFLD) to its more dangerous and deadly states — advanced fibrosis and cirrhosis.
March 11, 2014
March 11, 2014 —
…Sulpizio Cardiovascular Center where a multidisciplinary team implanted a novel cardiac device under her skin, leaving the heart untouched, to prevent sudden cardiac arrest.
April 29, 2020
April 29, 2020 —
UC San Diego Health has launched a Phase III clinical trial to assess whether a medication used to treat rheumatoid might also have therapeutic value for patient with COVID-19 who have developed or are at high risk of developing serious lung damage from SARS-CoV-2 infections.
September 18, 2014
September 18, 2014 —
UC San Diego Sulpizio Cardiovascular Center (SCVC) has been named among “100 Hospitals with Great Heart Programs” by Becker’s Hospital Review, a business and legal news publication for hospital and health system leadership.
July 6, 2018
July 6, 2018 —
…regulation and tumor suppression—could be applied to new cancer treatments…if only scientists could study them directly in living organisms. Tackling this task with a brand of chemistry that addresses biological challenges, University of California San Diego Professor Neal Devaraj produced research results that confront the limitations of studying ceramides.
November 14, 2022
November 14, 2022 —
A multi-campus research team has developed a novel device for non-invasively measuring cervical nerve activity in humans. The device, described in an article in Scientific Reports, has potential applications for supporting more personalized treatments for sepsis and PTSD.
April 25, 2024
April 25, 2024 —
Scientists from the University of California San Diego discovered a novel signaling pathway in liver cells, leading to a treatment for fibrosis.